Adjuvant effects of antineoplastic prostaglandins to cisplatin in nude mice bearing human ovarian cancer cells

This publication has 16 references indexed in Scilit:

• Human ovarian cancer cell lines resistant to cisplatin, doxorubicin, and l-phenylalanine mustard are sensitive to Δ7-prostaglandin Δ1 and Δ12-prostaglandin J2
  Gynecologic Oncology, 1991
• Adjuvant effects of prostaglandin D2 to cisplatin on human ovarian cancer cell growth in nude mice
  European Journal of Cancer and Clinical Oncology, 1988
• ANTITUMOR-ACTIVITY OF DELTA-7-PROSTAGLANDIN A1 AND DELTA-12-PROSTAGLANDIN J2 INVITRO AND INVIVO
  1986
• INHIBITION OF HUMAN-MELANOMA GROWTH BY PROSTAGLANDIN-A, PROSTAGLANDIN-D, AND PROSTAGLANDIN-J ANALOGS
  1986
• Δ12-prostaglandin J2, an ultimate metabolite of prostaglandin D2 exerting cell growth inhibition
  Biochemical and Biophysical Research Communications, 1985
• Prostaglandin D2 inhibits the proliferation of human malignant tumor cells
  Prostaglandins, 1984
• Prostaglandin D2 strongly inhibits growth of murine mastocytoma cells
  Prostaglandins, Leukotrienes and Medicine, 1983
• Inhibition of B-16 melanoma growth by prostaglandin D2
  Prostaglandins, 1983
• 9-Deoxy-Δ9-prostaglandin D2, a prostaglandin D2 derivative with potent antineoplastic and weak smooth muscle-contracting activities
  Biochemical and Biophysical Research Communications, 1982
• Clinical problems of resistance to cancer chemotherapeutic agents.
  1979